Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2018-03-05 Regulatory Filings
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
AIM Notice (17)
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains an 'AIM Rule 17 Notice' regarding a director's disclosure of a related company entering liquidation. This type of announcement, which details personal share transactions or related party dealings by directors, falls under the category of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content points directly to DIRS, which is a more precise classification than the general RNS fallback. The document length is short (1688 chars), but the content is a specific disclosure, not an announcement of a larger report.
2018-03-05 English
London Investor Evening
Report Publication Announcement Classification · 1% confidence The document is a short announcement (1726 chars) released via RNS (RNS Number : 9140E) on February 15, 2018. It announces that the Chairman will be presenting at a London Investor Evening hosted by Turner Pope Investments on February 26, 2018. This is not a full report (like 10-K or IR), nor is it a standard earnings release (ER) or a formal AGM notice. It is an announcement about an upcoming event where company information will be shared with investors. This fits best under the general category of investor relations communication, specifically announcing an event, which aligns closely with the purpose of an Investor Presentation (IP) or a general Regulatory Filing (RNS). Given the context of announcing a presentation to investors, 'Investor Presentation' (IP) is a strong candidate, but since the document itself is just the announcement of the event, and not the presentation slides or the presentation content, it is safer to classify it as a general regulatory announcement via RNS, or potentially a precursor to an investor event. Since it is a specific announcement about an event where the company will present, and it is distributed via RNS, I will check the definitions. It is not a DEF 14A (Remuneration), DVA (Voting Results), or DIV (Dividend). It is an announcement about an event where the company will present information to investors. This is closest to an Investor Presentation (IP) announcement, but since it's a brief notice about an event, and it is explicitly marked as an RNS release, 'RNS' (Regulatory Filings) serves as the most accurate general classification for this type of market communication that doesn't fit a more specific report type, especially given the 'MENU VS MEAL' rule suggesting short announcements might default to RPA or RNS. Since it's not announcing the publication of a report, RPA is less suitable than RNS for a general market update.
2018-02-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is very short (1316 characters) and begins with an 'RNS Number', indicating it is a regulatory announcement from the London Stock Exchange's news service. The content explicitly states that the company received notification regarding a change in shareholding ('Alto Invest no longer holds a notifiable interest in the Company'). This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is an announcement, the specific nature of the content (change in significant ownership) overrides the general 'RPA' rule, as MRQ is a more specific category for this type of filing than a general report announcement.
2018-02-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number : 1713E" and contains the standard format for a "TR-1: Standard form for notification of major holdings". This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The content details the person subject to notification (Aviva plc & its subsidiaries), the date the threshold was crossed (05/02/2018), and the resulting percentage of voting rights (7.27%). This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2018-02-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement by the header 'RNS Number : 8539D' and the footer 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'Notification of Major Interest' where Lanstead increased its holding in ImmuPharma PLC to 5.01%. This type of mandatory disclosure regarding changes in significant share ownership thresholds (crossing 5%) falls under the category of Major Shareholding Notification (MRQ). However, since the document itself is the official regulatory announcement format (RNS) detailing the event, and the primary identifier is the RNS number, RNS is a strong candidate. Reviewing the definitions: MRQ is for the notification of changes in significant share ownership levels. RNS is the general regulatory announcement fallback. Since the content perfectly matches the description for Major Shareholding Notification (MRQ), that is the most specific classification. The document structure is that of a regulatory filing announcement, not a full report, but MRQ is more specific than RNS for this content type.
2018-02-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled as an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The content details the acquisition/disposal of voting rights by 'Lanstead Capital LP' and the resulting percentage holding (4.90%). This fits the 'Major Shareholding Notification' category (MRQ) better than the general 'Regulatory Filings' (RNS), although RNS is the distribution channel.
2018-01-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.